Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The CRISPR baby furor is a clarion call to scientific and government bodies to define acceptable candidate diseases and minimal technical requirements for germline gene editing and to redouble outreach to, and oversight of, IVF clinics.
As clinical evidence mounts demonstrating the power of combining oncolytic viruses and checkpoint inhibitors, companies are scrambling to get in on the action.
A new European Union policy could increase the supply of legitimate pharmaceuticals in developing countries and thereby minimize the problem of counterfeit medicines, but many challenges remain.
An engineered oncolytic herpesvirus shows enhanced intratumoral spread, resistance to NK cell clearance and improved efficacy against brain cancer in mice.
The bioeconomy demands special approaches for attracting youth to science, technology, engineering and mathematics disciplines and cultivating the multidisciplinary skills needed for a future workforce.
